• Home
  • Contact Us
  • Français
  • About Us
    • Vision
    • Who We Are
    • Why Choose King
    • Strategy
    • Fast Facts
  • |
  • Products
    • EpiPen.ca
    • Cytomel
  • |
  • Newsroom
    • FAQs
  • |
  • Business Development

News

It’s Life and Death: Canadian Actress Speaks Out About Living with Severe Allergies

EpiPenŽ Partners with Lucy Waverman, Canadian Culinary Personality,
to Offer Fresh, Natural Recipes for People Who Suffer from Life-Threatening Allergies

New Study Shows Most Canadians Not Prepared for Potentially Fatal Allergic Reactions

Montréal Broadcaster Normand Brathwaite Advises Quebeckers to Prepare for Allergy Season

King Pharmaceuticals Canada Launches EpiPen® Expiration Reminder

King Pharmaceuticals Acquires Exclusive Rights to EpiPen® in Canada

CYTOMEL®
(liothyronine sodium tablets)

Therapeutic Area: Metabolics

This product is distributed by:

  • King Pharmaceuticals Canada, Inc. (Canada)
  • King Pharmaceuticals, Inc. (U.S.)

Full Prescribing Information (pdf 151 KB)

Cytomel is a registered trade mark of King Pharmaceuticals Research and Development, Inc. a wholly owned subsidiary of King Pharmaceuticals, Inc.

Get Adobe Reader
  • Home
  • About Us
  • Products
  • Newsroom
  • Business Development
  • Contact Us
  • Site Map
  • Legal
  • King Pharmaceuticals, Inc.

©2011 King Pharmaceuticals,® Inc. All rights reserved.

 

King Pharmaceuticals is now part of Pfizer Inc. The integration of King and Pfizer entities may be pending in various local jurisdictions and integration may be subject to completion of various local legal and regulatory obligations. All content in this message is subject to works council and/or union consultations, if applicable, and other legal requirements where appropriate.